To summarize, we found that recurring therapy Along with the synthetic cannabinoid JWH-018 would not lead to significant adjustments in 5-HT2A receptor responsiveness in rats, but provides transient increases in 5-HT1A receptor responsiveness. These findings, not like information created working with other synthetic cannabinoids, do not aid the riv